Inactive Instrument

All News AIT Therapeutics Inc Nasdaq

Equities

US0014481099

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Beyond Cancer Selected to Present on the Clinical Development of Ultra-High Concentration Nitric Oxide (UNO) Therapy at the 2024 American Society of Clinical Oncology Annual Meeting	01/05	AQ
Truist Lowers Price Target on Beyond Air to $8 From $10, Keeps Buy Rating	30/04	MT
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants	20/03	AQ
Beyond Air : Corporate Presentation	13/03	PU
Beyond Air, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	13/02	CI
Beyond Air, Inc. Provides Revenue Guidance for the Fiscal Year 2025	13/02	CI
Transcript : Beyond Air, Inc., Q3 2024 Earnings Call, Feb 12, 2024	13/02
Earnings Flash (XAIR) BEYOND AIR Posts Q3 Revenue $391,000, vs. Street Est of $0.45M	13/02	MT
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024	13/02	AQ
North American Morning Briefing : Stock Futures Steady as Traders Await CPI Data	12/02	DJ
Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast	18/01	AQ
Beyond Air Affiliate Says First Group Cleared in Phase 1 UNO Study in Solid Tumors; Shares Rise	27/12	MT
Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors	27/12	AQ
Thinking about buying stock in Polished.Com, Mereo BioPharma, Fusion Pharmaceuticals, Luminar Technologies, or Beyond Air?	20/12	PR
Beyond Air Insider Bought Shares Worth $1,962,000, According to a Recent SEC Filing	20/12	MT
Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference	16/11	AQ
Truist Cuts Beyond Air's Price Target to $10 From $14, Maintains Buy Rating	14/11	MT
Thinking about buying stock in Invo Bioscience, Singing Machine Company, Beauty Health, Beyond Air, or Tivic Health Systems?	14/11	PR
Beyond Air, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11	CI
Transcript : Beyond Air, Inc., Q2 2024 Earnings Call, Nov 13, 2023	14/11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News AIT Therapeutics Inc Nasdaq

Equities

US0014481099

All News

Filters